L-873724 | m-entrepreneurship.com

Product Name :
L-873724

Search keywords :
L-873724

drugId :
null

Target Vo:
Bone resorption factor

Target Vo Short Name :
Bone resorption factor

Moa_Name:
Bone resorption factor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Celera

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Osteoporosis, Postmenopausal

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
DDIT3 Antibody Autophagy
alpha Tubulin Rabbit mAb web
mOrange Tag Antibody (YA880): mOrange Tag Antibody (YA880) is an unconjugated, mouse-derived, anti-mOrange Tag (YA880) monoclonal antibody. mOrange Tag Antibody (YA880) can be used for: WB expriments in species-independent background without labeling.

Author: Betaine hydrochloride

Related Posts